Papers 11–16 of
16
by Rebecca A Clewell
- MM Miller, PD McMullen, ME Andersen, and RA Clewell. Multiple receptors shape the estrogen response pathway and are critical considerations for the future of in vitro-based risk assessment efforts. Crit Rev Toxicol 47 (7) : 564-580 (Aug 4, 2017). [abstract] [pubmed]
- B Sun, SM Ross, S Rowley, Y Adeleye, and RA Clewell. Contribution of ATM and ATR kinase pathways to p53-mediated response in etoposide and methyl methanesulfonate induced DNA damage. Environ Mol Mutagen 58 (2) : 72-83 (Mar 14, 2017). [abstract] [pubmed]
- B Foley, DL Doheny, MB Black, SN Pendse, BA Wetmore, RA Clewell, ME Andersen, and C Deisenroth. Editor's Highlight: Screening ToxCast Prioritized Chemicals for PPARG Function in a Human Adipose-Derived Stem Cell Model of Adipogenesis. Toxicol Sci 155 (1) : 85-100 (Jan 23, 2017). [abstract] [pubmed]
- MM Miller, RA Alyea, C LeSommer, DL Doheny, SM Rowley, KM Childs, P Balbuena, SM Ross, J Dong, B Sun, RA Clewell, and ME Andersen. Editor's Highlight: Development of an In vitro Assay Measuring Uterine-Specific Estrogenic Responses for Use in Chemical Safety Assessment. Toxicol Sci 154 (1) : 162-173 (Nov 7, 2016). [abstract] [pubmed]
- RA Clewell, and ME Andersen. Approaches for characterizing threshold dose-response relationships for DNA-damage pathways involved in carcinogenicity in vivo and micronuclei formation in vitro. Mutagenesis 31 (3) : 333-40 (May 4, 2016). [abstract] [pubmed]
- RA Clewell, PD McMullen, Y Adeleye, PL Carmichael, and ME Andersen. Pathway Based Toxicology and Fit-for-Purpose Assays. Adv Exp Med Biol 856 : 205-230 (Jan 1, 2016). [abstract] [pubmed]